Latest Women’s Health News

If you are looking for information, tips, and answers to women’s health questions, you have come to the right place. As a program of the Cleveland Clinic Center for Specialized Women’s Health, we can offer you expert advice and current articles from the women’s health community about maturing women related health topics, including:

  • Dietary concerns
  • Fitness
  • Menopause management
  • Necessary medical tests
  • Nutrition
  • Osteoporosis prevention

You’ll also find cutting edge women’s health news from the Cleveland Clinic, as well as developments from other women’s health news outlets all within the Speaking of Women’s Health community section.

Make sure to stay up-to-date on current women’s health news, articles and videos by viewing the releases below.

  • Colorectal cancer screening should start at age 45, not 50, American Cancer Society says

    May 2018 -- The American Cancer Society, responding to a rise in colorectal cancer rates among younger people, is now recommending that adults undergo screening for the disease beginning at age 45 rather than 50.

    The organization, which announced the change in its guidelines Wednesday, said extensive analysis showed that lowering the starting age for screening would save lives. The recommendations apply to adults who are at average risk of the disease; this includes most people in the United States.

    Read more…
  • IMVEXXY™ (estradiol vaginal inserts) approved for the treatment of moderate to severe dyspareunia

    May 2018 -- TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women's healthcare company, today announced that the United States Food and Drug Administration (FDA) has approved IMVEXXY™ (estradiol vaginal inserts) for the treatment of moderate-to-severe dyspareunia (vaginal pain associated with sexual activity), a symptom of vulvar and vaginal atrophy (VVA), due to menopause. 

    Read more…
  • ​FDA Approves Novel Preventive Treatment For Migraine​

    May 2018 -- The U.S. Food and Drug Administration today approved Aimovig (erenumab-aooe) for the preventive treatment of migraine in adults.

    Read more…
  • Remove barriers and simplify the regimen to increase access to contraception

    April 2018 -- Clinicians should target a regimen for birth control that is simple and medically appropriate to help cut down on the significant rate of unintended pregnancies, Pelin Batur, MD, NCMP, CCD, education director in primary care women’s health at the Cleveland Clinic, told Healio Family Medicine. “With all contraceptives, when you put human error into it, the effectiveness goes down,” Batur said.

    Another step practices can take to improve use of contraception is to recognize that screening for conditions such as sexually transmitted infections, breast cancer and cervical cancer, while important, are not prerequisites for starting contraception and could be a barrier to treatment, she said.  

    Read more…
  • Severity of Menopause Symptoms Could Help Predict Heart Disease

    New study evaluates effect of menopause and depression on vascular function.

    Read more…
  • Clinical Challenges: Osteoporosis Prevention in Menopause

    March 2018 -- Menopause can have a substantial impact on a woman's bone density and risk for osteoporosis, but there is no one-size-fits-all strategy for dealing with the issue. Dr. Holly L. Thacker and other women health experts weigh in on when, how to prevent osteoporosis in midlife women.

    Read more…
  • Targeting Healthcare for Women Patients

    March 2018 -- Hospitals and medical institutions across the country are offering more programs specifically designed with the needs of women patients in mind.

    Speaking of Women's Health Executive Director Dr. Holly L. Thacker discusses how women’s health needs are affected by reproductive factors, life cycle, hormones, and genetics, and women metabolize some medications differently and can have expressions of disease that are different from those in men.

    Read more…
  • Novel Oral Tx Dramatically Reduces Menopausal Flushing

    A new class of drugs for menopausal hot flushes works within three days (75% reduction) and does not increase estrogen levels. Bringing hope to women - especially those who can’t take hormone therapy .

    Read more…
  • Estrogen Therapy: Economic Considerations

    Author: Sarrel, Philip M. MD

    March 2018 by The North American Menopause Society - The high cost of health care for untreated menopausal women continues to be a subject of current interest. The NAMS 2017 Hormone Therapy Position Statement section on Economic Considerations describes the association between moderate to severe vasomotor symptoms (VMS) "with lower levels of health status and work productivity and greater use of health resources." 

    Women with untreated VMS show increased direct healthcare costs, and also indirect costs related to impaired work ability and work loss. Driven by menopause-related symptoms and disease, the combined costs for office and emergency room visits, pharmacy, and hospitalization are substantial.

    Read more…
  • Association of Spontaneous Preterm Delivery and Future Maternal Cardiovascular Disease

    February 2018 -- Cardiovascular disease (CVD) risk factors are well established. However, little is known about a woman’s cardiovascular response to pregnancy, which appears to be an early marker of future maternal CVD risk. Spontaneous preterm delivery (sPTD) has been associated with a ≤3-fold increased risk of maternal CVD death later in life compared with having a term delivery. This review focuses on 3 key areas to critically assess the association of sPTD and future maternal CVD risk: (1) CVD risk factors, (2) inflammatory biomarkers of interest, and (3) specific forms of vascular dysfunction, such as endothelial function and arterial stiffness, and mechanisms by which each may be linked to sPTD. The association of sPTD with subsequent future maternal CVD risk suggests that a woman’s abnormal response to pregnancy may serve as her first physiological stress test. These findings suggest that future research is needed to understand why women with sPTD may be at risk for CVD to implement effective interventions earlier in a woman’s life.

    Read more…